COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
May 2014

19

May
2014

category:

503b Compounding

Hospira Recalls Another Drug Over Visible Particulates

Hospira Inc. is initiating a voluntary nationwide recall to the user level for one lot of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL) 20 mL Multidose Vial, NDC 0409-2267-20, Lot 36-225-DD, Expiration 12/01/2015. The recall is due to a confirmed customer report of embedded particulate within the glass vial and visible particles floating […]

read more

19

May
2014

category:

503b Compounding

Today’s Shortages

ASHP/FDA Carboplatin Solution for Injection Ethambutol Tablets Etomidate Inj

read more

16

May
2014

category:

503b Compounding

Kenya: Kisii Hospital Denies Drugs Shortage Report

THE Kisii government has dismissed media reports that there is a shortage of drugs at the Kisii Level Five Hospital. Hospital CEO Dr Enock Ondari said no patient had been turned away for lack of medicine. He said the hospital received Sh7 million worth drugs from the Kenya Medical Supplies Agency. Speaking to the Star […]

read more